Arriel Makembi Bunkete | Biological Networks | Research Excellence Award

Published on by Network Science

Dr. Arriel Makembi Bunkete | Biological Networks | Research Excellence Award

Kinshasa University Congo | Democratic Republic of the

Dr. Arriel Makembi Bunkete is a highly qualified nephrologist specializing in internal medicine, clinical nephrology, dialysis, and renal transplantation, with extensive international experience in clinical research, teaching, and complex patient care across mainland France, French Guyana, and the Democratic Republic of Congo. Since January 2025, he has served as a nephrologist and deputy renal transplant coordinator at the University Hospital Centre (CHU) of French Guyana, overseeing nephrology and transplantation care, dialysis programs, and medical and paramedical teams. He previously coordinated kidney transplant programs at Franck Joly Hospital and has been actively involved in research and teaching as deputy coordinator of the scientific research, teaching, and innovation pool for the nephrology sector at Guyana University Hospital. As the National Representative for the Young Nephrologist Platform of the European Renal Association, he contributes to European-level nephrology initiatives. Dr. Bunkete has also trained healthcare professionals as a lecturer at the Institut Supérieur des Sciences Infirmières PPPLUS and gained extensive clinical experience in France at Hôpital Pitié-Salpêtrière, Hôpital Foch, and the Association for the Use of Artificial Kidneys (AURA). His early career includes residency in internal medicine and nephrology at the University Clinics of Kinshasa, DRC, managing complex kidney diseases and intensive hospital care. Throughout his career, he has demonstrated expertise in coordinating multidisciplinary teams and advancing scientific research in kidney disease and integrated care approaches.

Profiles: Scopus | Orcid | Google Scholar

"Home Hemodialysis in French Guiana: Transforming logistical challenges into healthcare opportunities", AM Bunkete Bulletin de la Dialyse à, Domicile 8 (2), 2025.

"Hydroxyurea and Regression of Sickle Cell Nephropathy: Open Clinical Trial in a Pediatric Population in DR Congo", DB Kabasele, AM Bunkete, G Mbayabo, P Lumbala, O Matondo, M Aloni, Kidney360, 2025.

"Peritoneal dialysis in an infant with severe acute renal failure: dialysis performed in flight during a medical evacuation in French Guiana – A case report", AM Bunkete, M Belgrine, M Sidibe, S Bellony, T Davodun, I Djiconkpode, Home Dialysis Bulletin 8 (3), 2025.

"Extramembranous glomerulonephritis in French Guiana: from the primitive form to autoimmune atypical presentations (a report of 5 cases)", AM Bunkete, M Belgrine, M Sidibe, MM Diallo, GN Timem, T Davodoun, PAMJ Clinical Medicine 19 (5), 2025.

"Evaluation of the Tolerability and Efficacy of the Main Hemodialysis Techniques in Intensive Care", T Mabiala, KA Muamba, VHT Ha, G Makeya, R Ngwizani, D Betukumesu, Open Journal of Nephrology 15 (1), 2025.

Monti Chiara Carla | Technological Networks | Top Researcher Award

Published on by Network Science

Dr. Monti Chiara Carla | Technological Networks | Top Researcher Award

University of Insubria | Italy

Dr. Monti Chiara Carla is an accomplished medical professional with extensive experience in clinical governance, healthcare management, and quality control within Italy’s social-healthcare sector. Since March 2020, she has served as the Medical Director and Quality Control Lead for the RSA Area at KOS Care Srl, overseeing 56 facilities across eight Italian regions with over 6,000 beds. Her work focuses on clinical process optimization, risk management, accreditation, staff training, and the development of innovative healthcare services. Previously, from 2017 to 2020, she held key responsibilities in medical and quality management at KOS Care’s Central Health Directorate for Anni Azzurri Residences, managing 40 facilities and 4,000 beds, where she contributed to ethical clinical pathways, pharmaceutical governance, and healthcare compliance. Dr. Monti also served with the Don Pozzoli Onlus Foundation as Facility Doctor and Supervisory Body Member, and led the HALT2 Study promoted by the European Centre for Disease Prevention and Control, focusing on infection control in long-term care. Earlier in her career, she gained significant clinical experience in geriatric, rehabilitative, and neurological care through roles at several nursing homes including Foscolo, Carducci, and Vivaldi facilities, and in the Department of Plastic, Reconstructive, and Aesthetic Surgery at the Macchi Foundation Hospital in Varese. Her career reflects a strong commitment to advancing patient care quality, medical ethics, and organizational excellence within the healthcare system.

Profiles: Scopus

Featured Publications

"Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson’s Disease Unveiled in Peripheral Blood Mononuclear Cells", ACS Chemical Neuroscience, 2023", 143 Citations by 127 documents 7 Documents 5 h-index.

Hon-Yi Shi | Cost Effectiveness Analysis | Best Researcher Award

Published on by Network Science

Prof. Hon-Yi Shi | Cost Effectiveness Analysis | Best Researcher Award

Kaohsiung Medical University | Taiwan

Author Profile

Scopus

Early Academic Pursuits

Prof. Hon-Yi Shi laid a strong foundation in the field of healthcare administration and health economics, building expertise in cost-effectiveness analysis, econometrics, and health outcomes assessment. His early academic interests centered on exploring healthcare resource utilization and patient outcomes, which later evolved into a specialized focus on applying advanced statistical and computational techniques, such as machine learning, to medical outcome predictions.

Professional Endeavors

Beginning his academic career as an Assistant Professor in 2006 at Kaohsiung Medical University, Prof. Shi steadily advanced to Associate Professor in 2010 and achieved the rank of Professor in 2013, a position he continues to hold. Alongside teaching and research, he has played significant editorial roles, serving on the advisory boards of leading journals such as the Journal of Healthcare Management, Journal of Health Management, and the World Journal of Gastrointestinal Surgery. These positions highlight his influence in shaping healthcare research and policy discourse.

Contributions and Research Focus

Prof. Shi’s research has been marked by an impressive portfolio of funded projects spanning nearly two decades. His contributions focus heavily on cost-effectiveness analysis, patient quality of life, and healthcare policy evaluation across diverse medical conditions, including cancer, stroke, diabetes, and joint replacement surgeries. He has led pioneering projects integrating time series analysis, Markov modeling, and machine learning to forecast outcomes, assess treatment effectiveness, and guide evidence-based healthcare decision-making. His role as Principal Investigator in multiple large-scale studies-funded by prestigious bodies such as the National Science Council and Ministry of Science and Technology—underscores his leadership in advancing medical and health economics research.

Impact and Influence

The scope of Prof. Shi’s research demonstrates both national and international relevance. His systematic reviews, meta-analyses, and prospective cohort studies have not only contributed to academic literature but also provided practical insights into healthcare resource allocation, patient-centered outcomes, and cost-effective policy design. By bridging healthcare management and computational modeling, his work has influenced both the academic community and healthcare providers in adopting data-driven approaches.

Academic Citations and Recognition

Prof. Shi’s consistent publication record and service on editorial boards have earned him significant recognition in the academic community. His research contributions, particularly in cost-effectiveness analysis and health outcomes, continue to be widely cited in healthcare economics and policy studies. His long-standing involvement in peer-reviewed journals demonstrates his active role in knowledge dissemination and mentorship within the academic community.

Legacy and Future Contributions

Looking ahead, Prof. Shi’s ongoing projects highlight his forward-thinking vision in applying machine learning and deep learning algorithms to predict long-term outcomes, hospital readmissions, and quality of life among patients with cancer, stroke, and other chronic conditions. His latest projects-such as forecasting complications in joint arthroplasty and evaluating robotic versus laparoscopic surgeries-demonstrate his commitment to improving patient care through innovative modeling and cost-effectiveness frameworks. His future legacy will likely lie in advancing interdisciplinary healthcare research, integrating AI, clinical outcomes, and health economics into a holistic model of sustainable healthcare improvement.

Conclusion

Prof. Hon-Yi Shi stands as a distinguished scholar whose career exemplifies dedication to healthcare research, innovation, and policy relevance. Through his extensive contributions in cost-effectiveness analysis, patient outcomes research, and machine learning applications, he has established himself as a leading figure in healthcare economics and management. His journey from early academic pursuits to becoming a renowned professor and research leader reflects both scholarly excellence and societal impact, ensuring that his work will continue to guide the future of evidence-based healthcare decision-making.

Notable Publications

"Clinical outcomes and cost-utility analysis of GKRS plus TKIs versus TKIs in patients with EGFR-mutant lung adenocarcinoma and brain metastases: a Markov decision model" 

  • Author: Liu SA, Lee CC, Yang HC, Huang WL, Huang YH, Chung WY, Shi HY
  • Journal: J Neurosurg
  • Year: 2025

"Impact of Post-Acute Care on Depression and Anxiety in Patients With Stroke: Cognitive Function as a Mediator and Moderator" 

  • Author: Lou SJ, Lin HF, Sheu CC, Hsu HY, Shi HY
  • Journal: Asian J Soc Health Behav
  • Year: 2025

"Quality of Life and Minimal Clinically Important Difference in Colorectal Cancer Patients Undergoing HIPEC: A Large Prospective Cohort Study" 

  • Author: Chiu CC, Hsieh MC, Wang GL, Shi HY
  • Journal: Ann Surg Oncol
  • Year: 2025

"Clinical Efficacy and Cost Effectiveness of SGLT2i in Diabetic Nephropathy: A Large Population-based Study" 

  • Author: Wang HH, Chiu YW, Chung CY, Liao YM, Lee YH, Kuo HM, Shi HY
  • Journal: Diabetes Res Clin Pract
  • Year: 2025

"Cost-Utility Analysis of Tenofovir Alafenamide and Entecavir in Chronic Hepatitis B Patients: A Markov Decision Model" 

  • Author: Lai CH, Shi HY,* Tsai CE, Yang YC, Chiu SF
  • Journal: Cancers (Basel)
  • Year: 2024

Dimitrios G. Tsoukas | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Dimitrios G. Tsoukas | Biological Networks | Best Researcher Award

Mitera Hospital Athens | Greece

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Dr. Dimitrios G. Tsoukas began his academic journey with exceptional distinction, graduating with a Bachelor in Medicine from the National and Kapodistrian University of Athens Faculty of Medicine. His early academic excellence set the foundation for a career rooted in clinical precision and innovative thinking. His education emphasized not only traditional orthopaedic surgery but also introduced him to minimally invasive techniques, which would later define his clinical signature.

PROFESSIONAL ENDEAVORS

Dr. Tsoukas's professional career spans over two decades of dynamic clinical and academic leadership. Currently, he serves as the Director of the E’ Orthopaedic Clinic for Advanced Arthroscopic Sports and Regenerative Surgery at MITERA Hospital (HH Group). He is also an Adjunct Professor at the University of Nebraska-Lincoln (USA) and has held numerous leadership positions at top hospitals across Greece and Cyprus. His pioneering efforts led to the founding of MIOSMED Center, an internationally recognized teaching hub endorsed by ISAKOS, ESSKA, and ICRS, and the Elite Regenerative Clinic Athens, a Lipogems SpA Center of Excellence. His clinical footprint spans not only orthopaedics but also women’s health, athletic injuries, and sports medicine innovation.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Tsoukas is a distinguished authority in arthroscopic, minimally invasive, and regenerative orthopaedic surgery, with special emphasis on adipose-derived stem cell applications for arthritis and joint degeneration. His contributions include advanced biological techniques in cartilage regeneration, joint preservation, and tendon repair. He has played a leading role in global education by serving as a certified instructor for ESSKA, contributing to simulation-based medical training, and mentoring young surgeons. His research interests include low-cost arthroscopy simulators, stem cell therapies, sports injury prevention in children, and medical device innovation.

IMPACT AND INFLUENCE

Dr. Tsoukas is recognized as a Key Opinion Leader (KOL) in orthopaedics and regenerative medicine, actively shaping clinical best practices and treatment protocols. His influence is reflected through editorial board memberships, reviewer roles for high-impact journals like the British Journal of Sports Medicine and the Orthopaedic Journal of Sports Medicine, and his participation in international regulatory and scientific committees. His appointment as a TEDx speaker in Kigali, Rwanda (2023) further underscores his role in global medical outreach and inspiration.

ACADEMIC CITES

As a scientific collaborator, Dr. Tsoukas has contributed to various institutions including the Athens University Medical School, Medical Physics Laboratory Simulation Center, and the European University of Cyprus. He has been involved in academic teaching, research, and publication, significantly advancing clinical education in Europe and the United States. He also served as Editor-in-Chief of the Journal of Stem Cell Research, and is a respected peer reviewer, ensuring academic rigor across multiple orthopaedic publications.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Dimitrios G. Tsoukas’s legacy is deeply embedded in medical innovation, education, and regenerative orthopaedics. As a fellow member of ICRS (2024) and an American Board of Regenerative Medicine Diplomat, he continues to push the boundaries of biological orthopaedic science. His ongoing leadership in global campaigns like “STOP Sports Injuries in Children” and collaborative research with biotechnology leaders like Terumo BCT, Arthrex, and Lipogems positions him as a visionary in the future of personalized, minimally invasive care. His legacy will endure through the institutions he built, the surgeons he trained, and the global initiatives he leads.

HONORS AND RECOGNITIONS

Dr. Tsoukas has received numerous accolades recognizing his contributions to orthopaedic science and Greek athletics. Among these are the Silver Award for Surgical Innovation at the Boussias Healthcare Business Awards 2021, the Med Professionals Honor for Stem Cell Innovation (2022), and several sports awards acknowledging his contributions to Greek basketball and volleyball. He holds the rare distinction of being enlisted in the Guinness World Records for medical contributions to the record-setting Athinaikos female basketball team.

OTHER SIGNIFICANT AFFILIATIONS AND LICENSES

Dr. Tsoukas maintains international medical licensure in Switzerland and Dubai, and continues to collaborate with organizations such as ECOSEP, CEV, and Smith & Nephew’s European Knee Advisory Board. These affiliations highlight his global reach and his role in shaping orthopaedic protocols across continents. His role as Head Doctor for National and Professional Teams underscores his credibility and trust within elite athletic circles.

NOTABLE PUBLICATIONS

"Prospective Observational Study of a Non-Arthroscopic Autologous Cartilage Micrografting Technology for Knee Osteoarthritis" 

  • Author: Dimitrios Tsoukas; Ilie Muntean; Christos Simos; Ruben Sabido-Vera
  • Journal: Bioengineering
  • Year: 2023